Cleveland Clinic Medical Innovation Summit – Finding Healthcare IT Disruptors

Cleveland Clinic Innovation Summit 2014 General Session
Cleveland Clinic Innovation Summit 2014 General Session

2014 Theme: 

Cancer Treatment and Personalized Medicine

According to Cleveland Clinic, the Health IT Sector Raised $2.2 billion in venture capital funding in 2013.   Cleveland Clinic is looking for the next big thing.  The conference is focused on: Disruptive Technology, Efficiency Technology and Ecosystem Technology.

Over 1,500 clinicians, managed care company executives, pharmaceutical company and start-up entrepreneurs, and investors are here in Cleveland starting today for  Cleveland Clinic’s 12th Annual Medical Innovation Summit.

The New Ventures Healthcare Challenge kicked off with Inder Singh, Founder & CEO of Kinsa and winner of the 2013 Cleveland Clinic 2013 Challenge, along with Gary Fingerhut, Director of Innovation at Cleveland Clinic introduced the 2014 Cleveland Clinic Medical Innovation Summit Challenge.    The Challenge include company presentations from MedAware, Ocuvera, Biop medical, and Admetsys Corporation.

Challenge Panelists Include:

Confirmed speakers include:In the Innovation Base Camp, first up was a presentation of the vision for a world with instantaneous communication and sensing.

  • Jack Andraka, Inventor, Scientist, Cancer Researcher
  • Jeff Arnold, Chairman & CEO, Sharecare
  • Marsha Barwick, Director of Applied Sciences, Marshfield Clinic
  • Peter Buca, VP, Technology & Innovation, Parker Hannifin
  • Todd Clyde, EVP, Global Field Operations, Mindjet
  • Breanna DiGiammarino, Head of Cause, Indiegogo
  • Gary Fingerhut, Executive Director, Cleveland Clinic Innovations
  • Thomas Graham, MD, Chief Innovation Officer, Justice Family Chair in Medical Innovations; Vice Chair, Department of Orthopaedic Surgery, Cleveland Clinic
  • John Nottingham, Co-President, Nottingham Spirk
  • Denys Resnick, EVP, Strategic Programs, NineSigma, Inc.
  • Mark Smith, MD, Director, MedStar Institute for Innovation
  • Larry Stofko, EVP, The Innovation Institute
  • Risto Pribisich, Partner, Innovations, Information Technology and Intellectual Property (3iP), Benesch, Friedlander, Coplan & Aronoff LLP
  • Robert Smith, Economic Development Reporter, The Plain Dealer
  • Halle Tecco, Founder, Rock Health
  • Kevin Vigilante, MD, SVP, Booz Allen Hamilton
  • Nicholas J. Webb, CEO, Lassen Innovation
  • Samuel Wertheimer, Managing Director, Poliwogg
  • Richard Wesorick, Partner, Tarolli, Sundheim, Covell & Tummino LLP
  • Derek Young, Founder & CEO, i360medical Ltd

According to Cleveland Clinic, the Health IT Sector Raised $2.2 billion in venture capital funding in 2013.   Cleveland Clinic is looking for the next big thing.  The conference is focused on: Disruptive Technology, Efficiency Technology and Ecosystem Technology.

Michael F. Arrigo

Michael is Managing Partner & CEO of No World Borders, a leading healthcare management and IT consulting firm. He serves as an expert witness in Federal and State Court and was recently ruled as an expert by a 9th Circuit Federal Judge. He serves as a patent expert witness on intellectual property disputes, both as a Technical Expert and a Damages expert. His vision for the firm is to continue acquisition of skills and technology that support the intersection of clinical data and administrative health data where the eligibility for medically necessary care is determined. He leads a team that provides litigation consulting as well as advisory regarding medical coding, medical billing, medical bill review and HIPAA Privacy and Security best practices for healthcare clients, Meaningful Use of Electronic Health Records. He advises legal teams as an expert witness in HIPAA Privacy and Security, medical coding and billing and usual and customary cost of care, the Affordable Care Act and benefits enrollment, white collar crime, False Claims Act, Anti-Kickback, Stark Law, physician compensation, Insurance bad faith, payor-provider disputes, ERISA plan-third-party administrator disputes, third-party liability, and the Medicare Secondary Payer Act (MSPA) MMSEA Section 111 reporting. He uses these skills in disputes regarding the valuation of pharmaceuticals and drug costs and in the review and audit of pain management and opioid prescribers under state Standards and the Controlled Substances Act. He consults to venture capital and private equity firms on mHealth, Cloud Computing in Healthcare, and Software as a Service. He advises ERISA self-insured employers on cost of care and regulations. Arrigo was recently retained by the U.S. Department of Justice (DOJ) regarding a significant false claims act investigation. He has provided opinions on over $1 billion in health care claims and due diligence on over $8 billion in healthcare mergers and acquisitions. Education: UC Irvine - Economics and Computer Science, University of Southern California - Business, studies at Stanford Medical School - Biomedical Informatics, studies at Harvard Medical School - Bioethics. Trained in over 10 medical specialties in medical billing and coding. Trained by U.S. Patent and Trademark Office (USPTO) and PTAB Judges on patent statutes, rules and case law (as a non-attorney to better advise clients on Technical and Damages aspects of patent construction and claims). Mr. Arrigo has been interviewed quoted in the Wall Street Journal, New York Times, and National Public Radio, Fortune, KNX 1070 Radio, Kaiser Health News, NBC Television News, The Capitol Forum and other media outlets. See and for more about the company.

Leave a Reply